Company Filing History:
19 out of 575 
1 out of 22 
1 out of 924 
Years Active: 2010-2024
Title: Shingo Yamamoto: A Pioneer in Pharmaceutical Innovations
Introduction
Shingo Yamamoto, based in Osaka, Japan, is a remarkable inventor known for his significant contributions to the pharmaceutical industry. With an impressive portfolio of 20 patents, he has made notable advancements in drug development, particularly focusing on compounds that target critical cellular pathways.
Latest Patents
Among his latest patents, two stand out for their innovative approaches. The first is the purinone derivative hydrochloride, specifically designed to exhibit Btk-selective inhibitory activity. This compound not only boasts excellent metabolic stability but also high solubility and absorption, making it a promising therapeutic agent for diseases involving B cells and mast cells. The second patent relates to a BRK inhibitory compound, represented by a specific general formula. This compound has shown potential as a drug ingredient aimed at preventing and treating BRK-related diseases, including various forms of cancer.
Career Highlights
Shingo Yamamoto's career includes pivotal roles at leading pharmaceutical companies such as Ono Pharmaceutical Co., Ltd. His work has been instrumental in pushing the boundaries of what is possible in drug development, making substantial contributions to advancements in healthcare.
Collaborations
Throughout his career, Yamamoto has collaborated with esteemed colleagues, including Toshio Yoshizawa and Masakuni Kurono. Together, they have worked on innovative projects that have significantly impacted the pharmaceutical landscape.
Conclusion
Shingo Yamamoto's dedication to pharmaceutical innovation and his impressive track record of patents reflect his commitment to improving medical treatments. His work continues to inspire future inventors and researchers in the field, driving advancements that hold the potential to transform patient care.